Browsing Tag
RiboGalSTAR
2 posts
Ribo enters obesity RNAi race as RBD3133 moves toward first human study in Europe
Suzhou Ribo Life Science has filed for a European Phase I trial of RBD3133, taking its first obesity candidate toward human testing as multiple RNAi developers pursue INHBE as a potential fat-selective alternative or complement to incretin therapies.
Ribo Life Science raises HKD1.8bn in Hong Kong IPO amid strong institutional support for siRNA growth strategy
Ribo Life Science’s HKEX IPO raised HKD 1.83B for siRNA drug development. See how it could reshape RNA biotech investment trends in Asia. Read more.